CompoAtlas

GasSTOP

Natural health product licensed in Canada

Licence holder
ReNew Life Canada Ltd.
NPN or DIN-HM
80036717
Status
Active licence
Licence date
19 October 2012
Revision date
24 September 2024
Form
Capsule
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
bêta-D-fructofuranoside fructohydrolase

Source : Saccharomyces cerevisiae - cellule entière

2.5 mg
bêta-D-fructofuranoside fructohydrolase

Source : Saccharomyces cerevisiae - cellule entière

250 FCC SU
bêta-D-fructofuranoside fructohydrolase

Source : Invertase

2.5 mg
bêta-D-fructofuranoside fructohydrolase

Source : Invertase

250 FCC SU
alpha-D-Galactoside galactohydrolase

Source : Aspergillus niger - En entier

50 mg
alpha-D-Galactoside galactohydrolase

Source : Aspergillus niger - En entier

500 FCC GalU
alpha-D-Galactoside galactohydrolase

Source : alpha-Galactosidase

50 mg
alpha-D-Galactoside galactohydrolase

Source : alpha-Galactosidase

500 FCC GalU

Non-medicinal ingredients

Maltodextrine, Hypromellose

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Digestive aid. Digestive enzyme. Helps digest proteins. Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates such as vegetables, pulses/legumes/beans and whole grain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80036717

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line